In situ and real-time readout of nuclear mechanotransduction via single cell mechanics and site-specific fluorescence reporting

通过单细胞力学和位点特异性荧光报告原位实时读出核力转导

基本信息

项目摘要

PROJECT SUMMARY The goal of this R21 is to develop new tools for unveiling force-initiated activation of the gene transcription ma- chinery during nuclear mechanotransduction, using combined single-cell mechanics and site-specific fluores- cence reporting. Nuclear mechanotransduction is defined as direct gene activation by external force via cyto- skeletal force propagation to the chromatin. This process is critically important for the development and maintenance of weight-bearing structural tissues such as cartilage, tendons, ligaments, and associated con- nective tissues. Aberrant mechanotransduction contributes to the pathophysiology of osteoarthritis. Significant voids exist in our understanding of nuclear mechanotransduction, especially at the molecular level in real time. The most significant event is the critical moment at which mechanical force is translated into transcrip- tional activation of genes at the junction where chromatin is anchored to the inner nuclear membrane. Knowledge of this event would significantly advance our understanding of nuclear mechanotransduction and establish systematic correlation of mechanical cues with downstream gene activation. This would have wide impacts and novel applications in programming cell phenotype via mechanical cues and development of new theragnostic tools. Many mechanoresponsive genes are rapidly activated within a short timeframe, often seconds or minutes, suggesting that they are transcriptionally paused. It is established that rapid activation of transcrip- tionally paused genes requires the transcription factor cyclin-dependent kinase 9 (Cdk9). Recently, Cdk9 has been localized to the inner nuclear membrane. Our central hypothesis is that the kinase activity of Cdk9 can be used as a surrogate for imaging the activation of mechano-responsive genes in real time in-situ (Fig 1). Here we propose to develop new fluorescent reporters to monitor Cdk9 activity, localized at the inner nuclear membrane, upon activation using single-cell mechanics. Our new tools will enable us to visualize gene activation in situ, in real time among living cells via our site-specific fluorescence reporters upon mechanical perturbation at single cell level. Two specific aims are: (SA1) To develop and validate Cdk9 activity reporters as surrogates for imaging gene activation. (SA2) Corre- late mechanical cue parameters with gene activation in living cells utilizing the Cdk9 reporters, using single-cell mechanics and varying the location, magnitude, duration, direction, and frequency of the applied force. The conceptual innovation is that a reporter for Cdk9 activity serves a surrogate for visualizing force-initi- ated gene activation. The technical innovations include the design and production of site-specific Cdk9 fluores- cence reporters, the combined approach of using single-cell mechanics to deliver the designed mechanical cues, and AFM/confocal imaging to monitor the subsequent gene activation in real time and in-situ. The outcomes include: (a) visualizing real time and in situ nuclear mechanotransduction in living cells; (b) capturing the transcriptional activation of genes; (c) revealing signal network, including linker of nucleoskel- eton and cytoskeleton (LINC) complexes, nuclear envelope proteins and lamins that anchor chromatin to the perinuclear matrix; and (d) establishing correlation of transcriptional activation with mechanical cues e.g., mag- nitude, duration, direction (shear versus normal) of force, force modulation frequency and amplitude. These outcomes support our long-term objectives to (a) program gene activation and cellular signaling via me- chanical cues, and to generate a new and impactful tool for the scientific community to probe the cellular pro- cesses involved in nuclear mechanotransduction.
项目摘要 这个R21的目标是开发新的工具,用于揭示力启动的基因转录激活机制。 在核机械转导过程中,使用组合的单细胞力学和位点特异性荧光, cence报告。核机械力转导是指外力通过细胞核直接激活基因。 骨骼力传递到染色质。这一过程对发展和 维持承重结构组织,如软骨、肌腱、韧带和相关的结缔组织, 分泌组织异常的机械传导有助于骨关节炎的病理生理学。显著 在我们对核机械力转导的理解中存在着空白,特别是在真实的分子水平上。 时间最重要的事件是机械力转化为转录的关键时刻- 在染色质锚定到核内膜的连接处基因的正常激活。 这一事件的知识将大大促进我们对核机械转导的理解, 建立机械线索与下游基因激活的系统相关性。这将使 在通过机械线索编程细胞表型方面的影响和新应用,以及新的 theragnostic工具。 许多机械反应基因在短时间内迅速激活,通常是几秒钟或几秒钟。 分钟,表明它们在转录上暂停。它被确定为转录的快速激活- 暂停的基因需要转录因子细胞周期蛋白依赖性激酶9(Cdk 9)。最近,Cdk 9 被定位在内核膜上。我们的中心假设是Cdk 9的激酶活性可以 可用作在原位真实的时间成像机械响应基因激活的替代物(图1)。 在这里,我们建议开发新的荧光报告监测Cdk 9的活动,定位在内核 膜,使用单细胞力学激活后。 我们的新工具将使我们能够通过我们的工具在活细胞中真实的原位可视化基因激活 位点特异性荧光报告分子在单细胞水平上的机械扰动。两个具体目标是: (SA1)开发并验证Cdk 9活性报告基因作为成像基因激活的替代物。(SA2)Corre- 利用Cdk 9报告基因在活细胞中的基因激活的晚期机械提示参数,使用单细胞 力学和改变施加力的位置、大小、持续时间、方向和频率。 概念上的创新是,Cdk 9活动的报告者充当了可视化力初始的替代者, 基因激活。技术创新包括设计和生产特定地点的Cdk 9荧光剂- cence报告者,使用单细胞机制来传递设计的机械提示的组合方法, 和AFM/共聚焦成像,以监测随后的基因激活在真实的时间和原位。 结果包括:(a)可视化活细胞中的真实的时间和原位核机械转导; (b)捕获基因的转录激活;(c)揭示信号网络,包括核骨架的接头, 细胞核和细胞骨架(LINC)复合物、核被膜蛋白和核纤层蛋白,它们将染色质锚在细胞核上。 核周基质;和(d)建立转录激活与机械线索的相关性,镁,镁 强度、持续时间、力的方向(剪切力与法向力)、力调制频率和振幅。这些 结果支持我们的长期目标:(a)通过ME编程基因激活和细胞信号传导, 化学线索,并产生一个新的和有影响力的工具,为科学界探索细胞前体, 参与核机械转导的细胞。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Dominik R Haudenschild其他文献

Role of c-Maf in Chondrocyte Differentiation
c-Maf 在软骨细胞分化中的作用
  • DOI:
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    2.8
  • 作者:
    Eunmee M Hong;P. D. Di Cesare;Dominik R Haudenschild
  • 通讯作者:
    Dominik R Haudenschild
Early transient induction of IL-6 in a mouse joint injury model
IL-6 在小鼠关节损伤模型中的早期瞬时诱导
  • DOI:
    10.1016/j.joca.2013.02.484
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    7
  • 作者:
    J. Yik;Ziang Hu;B. Christiansen;Dominik R Haudenschild
  • 通讯作者:
    Dominik R Haudenschild
Cartilage Matrix Protein: Expression Patterns in Chicken, Mouse, and Human a
软骨基质蛋白:鸡、小鼠和人类的表达模式
c-Maf Transcription Factor Regulates ADAMTS-12 Expression in Human Chondrogenic Cells
c-Maf 转录因子调节人软骨细胞中 ADAMTS-12 的表达
  • DOI:
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    2.8
  • 作者:
    Eunmee M Hong;J. Yik;D. Amanatullah;P. D. Di Cesare;Dominik R Haudenschild
  • 通讯作者:
    Dominik R Haudenschild
The Oncogene LRF Stimulates Proliferation of Mesenchymal Stem Cells and Inhibits Their Chondrogenic Differentiation
癌基因 LRF 刺激间充质干细胞增殖并抑制其软骨分化
  • DOI:
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    2.8
  • 作者:
    J. Yik;Huan Li;C. Acharya;R. Kumari;F. Fierro;Dominik R Haudenschild;J. Nolta;P. D. Di Cesare
  • 通讯作者:
    P. D. Di Cesare

Dominik R Haudenschild的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Dominik R Haudenschild', 18)}}的其他基金

Multivalent Presentation of Growth Factors Regulates Cellular Responses
生长因子的多价呈现调节细胞反应
  • 批准号:
    9312194
  • 财政年份:
    2017
  • 资助金额:
    $ 37.51万
  • 项目类别:
Multivalent Presentation of Growth Factors Regulates Cellular Responses
生长因子的多价呈现调节细胞反应
  • 批准号:
    9468334
  • 财政年份:
    2017
  • 资助金额:
    $ 37.51万
  • 项目类别:
Novel Early Intervention to Prevent Post-Traumatic Osteoarthritis
预防创伤后骨关节炎的新型早期干预措施
  • 批准号:
    8360907
  • 财政年份:
    2012
  • 资助金额:
    $ 37.51万
  • 项目类别:
Novel Early Intervention to Prevent Post-Traumatic Osteoarthritis
预防创伤后骨关节炎的新型早期干预措施
  • 批准号:
    8507602
  • 财政年份:
    2012
  • 资助金额:
    $ 37.51万
  • 项目类别:
Identification of Mechanoresponsive Promoter Elements in Chondrogenesis
软骨形成中机械反应启动子元件的鉴定
  • 批准号:
    8099961
  • 财政年份:
    2011
  • 资助金额:
    $ 37.51万
  • 项目类别:
Identification of Mechanoresponsive Promoter Elements in Chondrogenesis
软骨形成中机械反应启动子元件的鉴定
  • 批准号:
    8249814
  • 财政年份:
    2011
  • 资助金额:
    $ 37.51万
  • 项目类别:
Identification of Mechanoresponsive Promoter Elements in Chondrogenesis
软骨形成中机械反应启动子元件的鉴定
  • 批准号:
    8461068
  • 财政年份:
    2011
  • 资助金额:
    $ 37.51万
  • 项目类别:

相似国自然基金

Agonist-GPR119-Gs复合物的结构生物学研究
  • 批准号:
    32000851
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
  • 批准号:
    24K12256
  • 财政年份:
    2024
  • 资助金额:
    $ 37.51万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
  • 批准号:
    24K19176
  • 财政年份:
    2024
  • 资助金额:
    $ 37.51万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
  • 批准号:
    10578068
  • 财政年份:
    2023
  • 资助金额:
    $ 37.51万
  • 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
  • 批准号:
    10933287
  • 财政年份:
    2023
  • 资助金额:
    $ 37.51万
  • 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
  • 批准号:
    10650593
  • 财政年份:
    2023
  • 资助金额:
    $ 37.51万
  • 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
  • 批准号:
    10649275
  • 财政年份:
    2023
  • 资助金额:
    $ 37.51万
  • 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
  • 批准号:
    10734158
  • 财政年份:
    2023
  • 资助金额:
    $ 37.51万
  • 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
  • 批准号:
    10784209
  • 财政年份:
    2023
  • 资助金额:
    $ 37.51万
  • 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
  • 批准号:
    10580259
  • 财政年份:
    2023
  • 资助金额:
    $ 37.51万
  • 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
  • 批准号:
    23K05057
  • 财政年份:
    2023
  • 资助金额:
    $ 37.51万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了